Literature DB >> 22249509

Clinical impact of renal dysfunction in heart failure.

Alberto Palazzuoli1, Matteo Beltrami, Savina Nodari, Peter A McCullough, Claudio Ronco.   

Abstract

Renal impairment in heart failure (HF) patients has been increasingly recognized as an independent risk factor for morbidity and mortality. In the most recent European and American guidelines for HF management, renal dysfunction was considered an index of poor prognosis independent of the presence of other traditionally investigated risk factors. Different mechanisms appear to be implicated in worsening renal function in patients with acute decompensated HF (ADHF) in contrast to chronic HF. In patients with acute ADHF, renal impairment has been attributed to renal hypoperfusion due to reduced cardiac output and decreased systemic blood pressure. In these patients, neurohormonal activation of the renin-angiotensin and sympathetic nervous systems plays a key role. In chronic and clinically stable HF, other mechanisms, including microvascular damage, oxidative stress, inflammation, and fibrosis, lead to a reduced number of functioning nephrons. Differentiating transient functional changes in renal filtration and acute renal tubular injury with loss of functioning nephrons is a critical step in understanding cardiorenal syndromes and selection of patients for novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22249509     DOI: 10.3909/ricm0581

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  3 in total

1.  Cardiac MRI assessment of the right ventricle pre-and post-kidney transplant.

Authors:  Abdulaziz Ahmed Hashi; G V Ramesh Prasad; Philip W Connelly; Djeven P Deva; Michelle M Nash; Weiqiu Yuan; Rachel M Wald; Ron Wald; Lakshman Gunaratnam; Charmaine E Lok; S Joseph Kim; Gauri R Karur; Kim A Connelly; Andrew T Yan
Journal:  Int J Cardiovasc Imaging       Date:  2021-01-21       Impact factor: 2.357

Review 2.  Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.

Authors:  Alberto Palazzuoli; Serge Masson; Claudio Ronco; Alan Maisel
Journal:  Heart Fail Rev       Date:  2014-03       Impact factor: 4.214

Review 3.  The Treatment of Heart Failure in Patients with Chronic Kidney Disease: Doubts and New Developments from the Last ESC Guidelines.

Authors:  Matteo Beltrami; Massimo Milli; Lorenzo Lupo Dei; Alberto Palazzuoli
Journal:  J Clin Med       Date:  2022-04-17       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.